Fluorouracil
CAS 51-21-8
Overview
Fluorouracil, sold under the brand name Adrucil among others, is a cytotoxic chemotherapy medication used to treat cancer. By intravenous injection it is used for treatment of colorectal cancer, oesophageal cancer, stomach cancer, pancreatic cancer, breast cancer, and cervical cancer
Anant Labs manufacture and furnish high quality Fluorouracil impurities for global markets. Our Fluorouracil EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS51-21-8
Mol. FormulaC4H3FN2O2
Mol. Weight130.078 g/mol
IUPAC5-fluoro-1H-pyrimidine-2,4-dione
SMILESC1=C(C(=O)NC(=O)N1)F
InChIInChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
InChI KeyGHASVSINZRGABV-UHFFFAOYSA-N
Synonyms
5-Fluorouracilfluorouracil51-21-8EfudexFluracilFluoroblastinCarzonalQueroplexFlurilPhthoruracilArumelTimazinFluracilumUlup5-FluoracilFluorouracilumFluro Uracil5 Fluorouracil5-Fluoruracil5-Fluoro-2,4(1H,3H)-pyrimidinedioneFluorouraciloFtoruracilEfurixEffluderm (free base)Fluroblastin5-Fluoropyrimidine-2,4-dioneFluoro-uracileFluoro-uraciloUracil, 5-fluoro-2,4(1H,3H)-Pyrimidinedione, 5-fluoro-Ro 2-97575-FaracilCinco FUFluorouracileNSC-198932,4-Dioxo-5-fluoropyrimidineFluorouricilTolakRo-2-97575-Fluoropyrimidin-2,4-diolNSC 19893DTXSID2020634U-8953FluouracilFluoro Uracil5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione5-FluracilU3P01618RTNSC19893Ro-29757DTXCID40634CHEBI:46345FlurodexHaemato fuFluorouracil GRY5 FU LederleFluoro Uracile ICNFluoro-Uracile ICN5 FU medac5 HU HexalDakota, Fluorouracile5 Fluorouracil biosynFlurablastinAccuSite5 FluorouracilumFluoro-uracil rocheRefChem:56970L01BC025-Fluoro-2,4(1H, 3H)-pyrimidinedione200-085-6Fluoruracil5-FUFluoroplexAdrucilCarac5-fluoropyrimidine-2,4(1H,3H)-dioneKecimeton5-fluoro-1H-pyrimidine-2,4-dioneEfudixFluri5-fluoropyrimidine-2,4-diol2,4-Dihydroxy-5-fluoropyrimidine5-Fluor-2,4-pyrimidindiol5-fluoro uracil5-fluoro-uracil5-FtouracylFluorouracil, 5-5-Fluoro-2,4-pyrimidinedione191047-65-15-Fluor-2,4-dihydroxypyrimidinMFCD00006018FUCHEMBL185MLS0000694985 FU191047-64-0191115-88-55FUPhtoruracilURFNCGC00015442-02EffludermSMR000038082Fluorouracile [DCIT]5-Fluoracil [German]5-Fluoracyl5-Fluoruracil [German]1004-03-1Fluorouracilum [INN-Latin]Fluorouracilo [INN-Spanish]Fluorouracil CreamCAS-51-21-8Fluoroplex (TN)5-Fluor-2,4-pyrimidindiol [Czech]Adrucil (TN)5-fluoro-1,3-dihydropyrimidine-2,4-dioneCCRIS 2582Carac (TN)5-Fluor-2,4-dihydroxypyrimidin [Czech]HSDB 3228SR-010000758815-Fluor-2,4(1H,3H)-pyrimidindion [Czech]EINECS 200-085-65-Fluor-2,4(1H,3H)-pyrimidindion2,4-Pyrimidinediol, 5-fluoro- (9CI)inhibits thymilidate synthetaseUNII-U3P01618RT2,4-Dioxo-5-fluoropryimidine5-fluorourasilAI3-25297Fluorouracil RS5-florouracil5-fluorouacil5-FU (TN)Fluorouracil CRS1upf5F-uracilU 8953Fluorouracil; 5-Fluoropyrimidine-2,4(1H,3H)-dione; Flucytosine Imp. A (EP); Flucytosine Impurity AAdrucil (ICN)2794-13-0Adrucil (Fluorouracil)Fluorouracil [USAN:USP:INN:BAN:JAN]Spectrum_000841Opera_ID_1345-Fluorouracil, 99%Spectrum2_000076Spectrum3_000434Spectrum4_000557Spectrum5_000718WLN: T6MVMVJ EFFLUOROURACIL [MI]Lopac-F-6627F01515-Fluorouracil (5-FU)FLUOROURACIL [INN]FLUOROURACIL [JAN]5-Fluorouracil (Standard)UPCMLD-DP130EC 200-085-6F 6627FLUOROURACIL [HSDB]FLUOROURACIL [USAN]SCHEMBL36465-fluorpyrimidin-2,4-diolFLUOROURACIL [VANDF]Folfox component fluorouracilLopac0_000536BSPBio_002048FLUOROURACIL [MART.]KBioGR_001253KBioSS_001321MLS002415705DivK1c_000054FLUOROURACIL [USP-RS]FLUOROURACIL [WHO-DD]FLUOROURACIL [WHO-IP]SCHEMBL592897SPECTRUM1500305SPBio_0002915-FLUOROURACIL [IARC]5-fluoro-2,4-dioxo-pyrimidin5-fluoro-pyrimidine-2,4-diolGTPL4789orb1310103orb3141274SCHEMBL2733944SCHEMBL8012255SCHEMBL10746579UPCMLD-DP130:001Fluorouracil (JP18/USP/INN)HMS500C16KBio1_000054KBio2_001321KBio2_003889KBio2_006457KBio3_0012685-Fluoro-2,3H)-pyrimidinedione5-FLUOROURACIL [WHO-IP]2,4-Pyrimidinedione, 5-fluoro-NINDS_000054FLUOROURACIL [ORANGE BOOK]GLXC-07719HMS1920O18HMS2090I04HMS2091F19HMS3259O03HMS3261L13HMS3654K22HMS3715H03HMS3865L03HMS5079C17Pharmakon1600-01500305FLUOROURACIL [EP MONOGRAPH]5-Fluorouracil, analytical standardMSK10715TCA941952,3H)-Pyrimidinedione, 5-fluoro-5-Fluorouracil - Bio-X trade markFluorouracil (5-Fluoracil, 5-FU)Fluorouracil (5-Fluoracil; 5-FU)FLUOROURACIL [USP MONOGRAPH]Tox21_110150Tox21_202335Tox21_300112Tox21_500536BDBM50340677CCG-39879DL-399EBC-00529EBC-44298EBC-50070HY-90006RNSC757036NSC816997s1209SBB085751STK297802STL367375FLUOROURACILUM [WHO-IP LATIN]AKOS000119162AKOS003237897AKOS008044307Tox21_110150_1CS-0993DB00544FF05372KS-5129LP00536NC00454NSC-757036NSC-816997SDCCGSBI-0050519.P005FLUCYTOSINE IMPURITY A [WHO-IP]Fluorouracil; Flucytosine EP Impurity AIDI1_000054NCGC00015442-01NCGC00015442-03NCGC00015442-04NCGC00015442-05NCGC00015442-06NCGC00015442-07NCGC00015442-08NCGC00015442-09NCGC00015442-10NCGC00015442-11NCGC00015442-12NCGC00015442-15NCGC00015442-16NCGC00015442-24NCGC00015442-30NCGC00091349-01NCGC00091349-02NCGC00091349-03NCGC00091349-04NCGC00091349-05NCGC00091349-07NCGC00091349-08NCGC00254023-01NCGC00259884-01NCGC00261221-01AC-11201BF166014EMTRICITABINE IMPURITY F [WHO-IP]HY-90006NCI60_001652SRI-10792-04SRI-10792-05SRI-10792-06SRI-10792_07SRI-10792_085-Fluoro-1H-pyrimidine-2,4-dione(5FU)5-Fluorouracil, >=99% (HPLC), powderSBI-0050519.P0042(1H)-Pyrimidinone, 5-fluoro-4-hydroxy-4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy-5-Fluoro-1H-pyrimidine-2,4-dione(5-FU)DB-051923DB-065735DB-268958DB-272209DB-297613pyrimidine-2,4(1H,3H)-dione, 5-fluoro-5-Fluoro-1H-pyrimidine-2,4-dione (5-FU)EU-0100536F4480FLUCYTOSINE IMPURITY A [EP IMPURITY]NS00000337ST45025877SW199617-35-Fluoro-1H-pyrimidine-2,4-dione(5-FUra)EN300-33909Fluorouracil, meets USP testing specifications3-Trifluoromethyl-4-(S)-2-butoxybenzoic acidC07649D005845-fluoro-6-hydroxy-1,2-dihydropyrimidin-2-one5-Fluorouracil, Vetec(TM) reagent grade, >=99%F003241Q238512W-60379(5-fluorouracil)5-Fluoro-1H-pyrimidine-2,4-dione4,4-(1,4-PHENYLENE-DI-2,1-ETHYNEDIYL)B5-Fluoro-1H-pyrimidine-2,4-dione(5-fluoro uracil)SR-01000075881-1SR-01000075881-3SR-01000075881-55-Fluoro-1H-pyrimidine-2,4-dione (5-Fluorouracil)BRD-K24844714-001-02-1BRD-K24844714-001-24-5BRD-K24844714-001-25-25-FLUOROPYRIMIDIN-2,4(1H,3H)-DIONE [WHO-IP]Z2751280525-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU)5-Fluorouracil, certified reference material, TraceCERT(R)Fluorouracil, British Pharmacopoeia (BP) Reference StandardFluorouracil, European Pharmacopoeia (EP) Reference StandardFluorouracil, United States Pharmacopeia (USP) Reference Standardpyrimidine antimetabolite: inhibits nucleic acid replication; tetratogenFluorouracil, Pharmaceutical Secondary Standard; Certified Reference MaterialInChI=1/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9635702-33-9665011-29-0